Organization Profile

You just read:

Health Canada Expands Indications of Abilify® (aripiprazole), to be the First Add-On Treatment for Major Depressive Disorder (MDD)

News provided by

Bristol-Myers Squibb Canada

Jun 06, 2013, 11:00 ET